TY - JOUR
T1 - The financial burden of diabetes-related foot disease in Australia
T2 - a protocol for a systematic review
AU - Frescos, Nicoletta
AU - Jansen, Shirley
AU - Stopher, Lucy
AU - Kaminski, Michelle R.
PY - 2022/12
Y1 - 2022/12
N2 - Background Diabetes-related foot disease (DFD) is one of the most common, costly and severe complications of diabetes, which poses a substantial burden on patients, healthcare systems and society. Contemporary data on the financial burden of DFD treatment in Australia is ambiguous. Therefore, the aim of this proposed protocol is to identify, summarise and synthesise existing evidence by undertaking a systematic review to estimate the costs associated with DFD treatment in Australia.Methods This systematic review will conduct searches in MEDLINE, Embase, AMED, CINAHL, Joanna Briggs Institute EBP and the Cochrane Library from November 2011 to November 2021. Peer-reviewed articles evaluating the costs associated with DFD treatment within Australia will be included. Study quality and risk of bias will be assessed using the Consolidated Health Economic Evaluation Reporting Standards (CHEERS 2022). A meta-analysis of estimated costs will be performed if data from included studies are sufficiently homogenous, otherwise, a narrative synthesis will be used.Discussion The results of this systematic review will provide insight into the current economic impact of DFD management within Australia. Such data may help to inform optimisation of national service delivery and result in improved outcomes for individuals with DFD in Australia.Registration PROSPERO Registration No. CRD42022290910
AB - Background Diabetes-related foot disease (DFD) is one of the most common, costly and severe complications of diabetes, which poses a substantial burden on patients, healthcare systems and society. Contemporary data on the financial burden of DFD treatment in Australia is ambiguous. Therefore, the aim of this proposed protocol is to identify, summarise and synthesise existing evidence by undertaking a systematic review to estimate the costs associated with DFD treatment in Australia.Methods This systematic review will conduct searches in MEDLINE, Embase, AMED, CINAHL, Joanna Briggs Institute EBP and the Cochrane Library from November 2011 to November 2021. Peer-reviewed articles evaluating the costs associated with DFD treatment within Australia will be included. Study quality and risk of bias will be assessed using the Consolidated Health Economic Evaluation Reporting Standards (CHEERS 2022). A meta-analysis of estimated costs will be performed if data from included studies are sufficiently homogenous, otherwise, a narrative synthesis will be used.Discussion The results of this systematic review will provide insight into the current economic impact of DFD management within Australia. Such data may help to inform optimisation of national service delivery and result in improved outcomes for individuals with DFD in Australia.Registration PROSPERO Registration No. CRD42022290910
KW - amputation
KW - cost analysis
KW - diabetic foot
KW - diabetes-related foot disease
KW - diabetes-related foot ulcer
KW - ULCERS
KW - COSTS
UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000904375000005
U2 - 10.33235/wpr.30.4.223-227
DO - 10.33235/wpr.30.4.223-227
M3 - Review article
SN - 1837-6304
VL - 30
SP - 223
EP - 227
JO - Wound Practice and Research
JF - Wound Practice and Research
IS - 4
ER -
